A phase II trial of Sativex in patients with spasticity due to cerebral palsy

Trial Profile

A phase II trial of Sativex in patients with spasticity due to cerebral palsy

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Dec 2016

At a glance

  • Drugs Nabiximols (Primary)
  • Indications Muscle spasticity
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Dec 2016 According to a GW Pharmaceuticals media release, data from the study is expected in the first quarter of 2017.
    • 05 Dec 2016 Status changed from active, no longer recruiting to completed, as reported in a GW Pharmaceuticals media release.
    • 10 Aug 2016 According to a GW Pharmaceuticals media release, status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top